27590630|t|A pH - Sensitive Nanocarrier for Tumor Targeting: Delivery of Ruthenium Complex for Tumor Theranostic by pH - Sensitive Nanocapsule
27590630|a|Ruthenium complex is a potentially theranostic agent for cancer imaging and therapy, however its application is limited due to poor water-solubility and lack of tumor selectivity. To overcome the above drawbacks, pH - sensitive nanocapsule as a novel targeting carrier was designed to deliver ruthenium complex for treating xenograft tumor of mice. The core / shell structured nanocapsule with ruthenium complex tris(1,10-phenanthroline) ruthenium(II) complex (3P-Ru) as the core and a pH - sensitive polymeric material poly (2-diisopropylaminoethyl methacrylate)-block poly(2-aminoethyl methacrylate hydrochloride) (PbPS) as the shell was synthesized and characterized. Meanwhile, the nanocapsule was used to investigate cell viability and evaluate tissue distribution as well as preventing tumor growth efficacy in U251 stem cells tumor -bearing mouse model. The nanocapsule had a size of 103.1 ± 11.3 nm, zeta potential of -40 ± 5.3 mV, EE of 76.7 ± 0.9%, LE of 25.4 ± 0.6% and it could control drug release under different pH conditions. The results of cell uptake showed that the fluorescent 3P-Ru loaded in the nanocapsule could be delivered into cells with high efficiency, and then significantly inhibited U251 proliferation in a concentration - dependent manner. After U251 stem cells were transplanted subcutaneously into mice, the 3P-Ru / PbPS nanocapsule (PbPS - Ru - NC) via intravenous administration could concentrate in tumor area and obviously prevent tumor growth. The pH - sensitive nanocapsule as a antitumor agent carrier was able to effectively deliver 3P-Ru into gliomas cells, and cell growth was significantly inhibited both in vitro and in vivo. Such pH - sensitive nanocapsule for ruthenium complex delivery would have great potential application in tumor theranostics.
27590630	17	28	Nanocarrier	T103	UMLS:C0013161
27590630	33	38	Tumor	T038	UMLS:C0027651
27590630	39	48	Targeting	T038	UMLS:C0599894
27590630	62	79	Ruthenium Complex	T103	UMLS:C0206450
27590630	84	89	Tumor	T038	UMLS:C0027651
27590630	90	101	Theranostic	T091	UMLS:C4042913
27590630	132	149	Ruthenium complex	T103	UMLS:C0206450
27590630	167	184	theranostic agent	T103	UMLS:C1254351
27590630	208	215	therapy	T058	UMLS:C0920425
27590630	293	298	tumor	T038	UMLS:C0027651
27590630	383	400	targeting carrier	T103	UMLS:C0013161
27590630	425	442	ruthenium complex	T103	UMLS:C0206450
27590630	456	471	xenograft tumor	T038	UMLS:C0027651
27590630	475	479	mice	T204	UMLS:C0025929
27590630	485	489	core	T082	UMLS:C0444669
27590630	498	508	structured	T082	UMLS:C0678594
27590630	526	543	ruthenium complex	T103	UMLS:C0206450
27590630	544	591	tris(1,10-phenanthroline) ruthenium(II) complex	T103	UMLS:C0284795
27590630	593	598	3P-Ru	T103	UMLS:C0284795
27590630	607	611	core	T082	UMLS:C0444669
27590630	633	651	polymeric material	T103	UMLS:C0032521
27590630	652	747	poly (2-diisopropylaminoethyl methacrylate)-block poly(2-aminoethyl methacrylate hydrochloride)	T103	UMLS:C0032521
27590630	749	753	PbPS	T103	UMLS:C0032521
27590630	854	868	cell viability	T038	UMLS:C0007620
27590630	949	970	U251 stem cells tumor	T017	UMLS:C1956421
27590630	980	991	mouse model	T038	UMLS:C2986594
27590630	1189	1193	cell	T017	UMLS:C0007634
27590630	1194	1200	uptake	T038	UMLS:C3888108
27590630	1217	1234	fluorescent 3P-Ru	T103	UMLS:C0284795
27590630	1285	1290	cells	T017	UMLS:C0007634
27590630	1346	1350	U251	T017	UMLS:C1956421
27590630	1351	1364	proliferation	T038	UMLS:C0596290
27590630	1410	1425	U251 stem cells	T017	UMLS:C1956421
27590630	1464	1468	mice	T204	UMLS:C0025929
27590630	1474	1479	3P-Ru	T103	UMLS:C0284795
27590630	1482	1486	PbPS	T103	UMLS:C0032521
27590630	1500	1504	PbPS	T103	UMLS:C0032521
27590630	1507	1509	Ru	T103	UMLS:C0206450
27590630	1520	1546	intravenous administration	T082	UMLS:C0013125
27590630	1568	1573	tumor	T038	UMLS:C0027651
27590630	1574	1578	area	T082	UMLS:C0205146
27590630	1651	1666	antitumor agent	T103	UMLS:C0003392
27590630	1707	1712	3P-Ru	T103	UMLS:C0284795
27590630	1718	1725	gliomas	T038	UMLS:C0017638
27590630	1726	1731	cells	T017	UMLS:C0007634
27590630	1737	1748	cell growth	T038	UMLS:C0007595
27590630	1795	1802	in vivo	T082	UMLS:C1515655
27590630	1840	1857	ruthenium complex	T103	UMLS:C0206450
27590630	1909	1914	tumor	T038	UMLS:C0027651
27590630	1915	1927	theranostics	T091	UMLS:C4042913